Free weekly newsletter
Get the free weekly contract digest
The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
Thor Medical Partners with Eckert & Ziegler to Enhance Access to Lead-212 for Cancer Treatment.
May 28, 2026•20 days ago
Contract Type
partnership
ManufacturingBiotechnologyHealth CareMedicalMedical Device
Description
Thor Medical has formed a partnership with Eckert & Ziegler to accelerate the development of lead-212 based therapies. This collaboration will strengthen the supply chain and manufacturing base for lead-212, supporting biotech and pharmaceutical companies in their research and development efforts.
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months